October 26, 2015

Tibial Tuberosity Advancement (TTA) System

Erik Asimus, Brian Beale, Randy Boudrieau, Loïc Déjardin, Michael Kowaleski

media-108384
Fig 1: A tibial tuberosity advancement procedure using the VET TTA system on a canine stifle.

Cranial cruciate ligament (CrCL) failure in dogs is a pervasive injury that results in abnormal joint motion, progressive osteoarthritis, meniscal lesions, and loss of function. Several high tibial osteotomies, among which the forerunner is the tibial plateau leveling osteotomy (TPLO), have been devised over the past 20 years to neutralize the cranial tibial thrust (CrTT) force. This tibiofemoral shear force is responsible for joint instability following CrCL failure. The Tibial Tuberosity Advancement (TTA) system has been used as an alternative to the TPLO to restore joint stability during weight-bearing.

Unlike the TPLO, which relies on a reduction of the tibial plateau slope via a radial osteotomy, neutralization of the CrTT with the TTA is achieved by advancing the tibial tuberosity until the angle between the straight patellar ligament and the tibial plateau remains 90 or less, regardless of the stifle joint flexion/extension angle. The advancement of the tibial tuberosity is allowed by creating an osteotomy of the tibial crest in the frontal plane followed by plate stabilization after placement of a wedge within the osteotomy to maintain the gap width. A bone graft is placed within the osteotomy gap to enhance healing. Furthermore, the TTA can be used to treat CrCL rupture cases with concomitant medial patellar luxation (MPL) via the use of offset spacers that induce a lateral transposition of the tibial crest.

System design

The TTA system (Fig 1) is indicated for the treatment of CrCL disease in canines. It is compatible with small and mini fragment systems and the plate is available in right and left versions as well as in the following sizes:

  • 2.4 mm/2.7 mm TTA plate: 53 mm (size 4) and 65 mm (size 5)
  • 2.4 mm/3.5  mm TTA plate: 78 mm (size 6), 90 mm (size 7) and 104 mm (size 8).

The locking screw trajectories in the proximal plate section are designed to optimize screw purchase within the tibial crest. Furthermore, the incorporation of locking technology (Fig 2) permits a fixed-angle device to increase construct stability.

Wedges and spacers are made of radiolucent PEEK (Fig 3). The Wedges are available in 8 widths (4.5, 6, 7.5, 9, 10.5, 12, 13.5 and 15 mm) and can easily be cut to the desired length to accommodate the tibial width using the graduated length markings. Additionally, 3 or 5 mm PEEK offset spacers may be snapped to the wedge allowing for simultaneous treatment of MPL (Fig 4).

media-108392
Fig 2: The TTA plate showing the proximal locking holes.
media-108368
Fig 3: Wedge with offset spacers (for treating MPL) both made of radiolucent PEEK.
media-108376
Fig 4: A tibial tuberosity transposition and advancement (TTTA) procedure using an offset spacer.

“approved by AO Technical Commission” and “approved by AO Foundation”
The brands and labels “approved by AO Technical Commission” and “approved by AO Foundation”, particularly "AO" and the AO logo, are AO Foundation's intellectual property and subject to trademark applications and registrations, respectively. The use of these brands and labels is regulated by licensing agreements between AO Foundation and the producers of innovation products obliged to use such labels to declare the products as AO Technical Commission or AO Foundation approved solutions. Any unauthorized or inadequate use of these trademarks may be subject to legal action.